未登录Neoadjuvant endocrine therapy and avelumab with or without palbociclib in stage II/III endocrine receptor-positive breast cancer: the ImmunoADAPT trial
Zavras, Phaedon; Chen, Ruizhe; Qi, Hanfei; Jones, Mary Kate; Folmer, Ann; Chae, Hayden; Khodab, Allen; Cimino-Mathews, Ashley; Jacobs, Lisa; Mullen, Lisa; Hiton, Christie; Elkhanany, Ahmed; Khoury, Katia; Cristofanilli, Massimo; Jaffee, Elizabeth; Stearns, Vered; Santa-Maria, Cesar .png)
分享.png)
收藏Phase II trial of palbociclib with fulvestrant in individuals with hormone receptorpositive, HER2-negative metastatic breast cancer with disease progression after palbociclib with an aromatase inhibitorTao, Jessica J.; Blackford, Amanda L.; Nunes, Raquel; Truica, Cristina I.; Mahosky, Justin; Jones, Mary Kate; Leasure, Nick C.; Cescon, Terrence; Christou, Antonios; Werner, Jeanine L.; Couzi, Rima; Smith, Karen L.; Santa-Maria, Cesar Augusto; Wolff, Antonio C.; Stearns, Vered 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Forman-Fixed, Paraffin-Embedded Tissue of Human Lung CancerEvrard, Solene M.; Taranchon-Clermont, Estelle; Rouquette, Isabelle; Murray, Samuel; Dintner, Sebastian; Nam-Apostolopoulos, Yun-Chung; Bellosillo, Beatriz; Varela-Rodriguez, Mar; Nadal, Ernest; Wiedorn, Klaus H.; Melchior, Linea; Andrew, Emma; Jones, Mary; Ridgway, Jennifer; Frykman, Christina; Lind, Linda; Rot, Mitja; Kern, Izidor; Speel, Ernst J. M.; Roemen, Guido M. J. M.; Trincheri, Nicol; Freiberger, Sandra N.; Rechsteiner, Markus 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
